Overexpression of mortalin has been shown to accelerate carcinogenesis by stimulating cell proliferation, epithelial-mesenchymal transition (EMT) program, and cancer cell stemness (Yun et al., 2017; Xu et al., 2020; Wei et al., 2021). This evidence concerns the gene HSPA9 and cancer.